Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Kevin Young CBEThe Department of Pharmacology is delighted to announce that Kevin Young CBE has made a sizable donation to the Department. Professor Frances Platt FRS FMedSci said, “This is one of the largest donations in the hundred-year history of the Department and we were also delighted that Mr Young joined our community as a Senior Research Fellow last year. His insight and experience in drug discovery will be greatly valued by the Department and the Medical Sciences Division.”

Kevin has worked for over 35 years in Biopharma, including ICI Pharmaceuticals, Amgen and Gilead. He retired in February 2018 as Chief Operating Officer with Gilead Sciences. During his tenure, Gilead transformed the treatment of multiple viral diseases, notably HIV, Hepatitis B, Hepatitis C and Influenza.

Kevin has degrees in Sports Science and Exercise and has 18 publications in human muscle physiology to his name. Originally from York, England, Kevin resides on the West Coast of the USA.

In 2011, Kevin was appointed ‘Commander of The Most Excellent Order of the British Empire’ in recognition of his contributions to the Biopharma Industry and Healthcare.

We are extremely grateful for his most generous gift and his membership of our community in Oxford.

Similar stories

Rosalind Franklin Institute and Pharmacology announce strategic partnership in Next Generation Chemistry

The Rosalind Franklin Institute and the University of Oxford’s Department of Pharmacology have entered into a strategic partnership for Next Generation Chemistry.

New insight into the pharmacology of a therapeutic ion channel target

A new paper, published by the Tammaro lab in the Proceedings of the National Academy of Sciences (PNAS), shines new light on potential sites for pharmacological intervention within TMEM16A channels.

J Harold Burn (1892-1981)

A world-leading pharmacologist who built up the Department

New BHF study offers potential of new clinical options for cardiac treatment

A new study, led by Professor Kim Dora in association with Professor Raimondo Ascione at the University of Bristol, has shown abnormalities in the tiny blood vessels of human hearts which cannot be detected by current heart scans. Poor myogenic (automatic) tone, where blood flow in these vessels is abnormal, is thought to develop independent of disease in the larger arteries, which can be treated using stents or bypass surgeries.

Professor Fran Platt elected to The Royal Society

We were delighted to learn from the announcement today, 6 May 2021, that Professor Fran Platt has been elected a Fellow of The Royal Society. She is one of the 52 distinguished scientists whose election was announced, and one of the two biologists out of six Oxford academics so-honoured this year.